Synapse Integrative Behavioral Health

Synapse Integrative Behavioral Health in Marlton, New Jersey offers Spravato (esketamine), the first nasal spray medication specifically for adults with treatment-resistant depression. Used alongside an oral antidepressant, Spravato targets NMDA receptors through a different pathway than standard antidepressants and may provide faster relief for patients who have not responded to traditional medications.

Patients self-administer the nasal spray under supervision, then rest in the office for a two-hour monitoring period during which the team checks blood pressure, heart rate, oxygen levels, and side effects before discharge. A ride home is required.

Treatment follows a schedule of twice weekly for the first month, then weekly or biweekly. Part of the Beacon network of physician-led practices, Synapse also offers TMS therapy with extended hours, along with psychiatric care and medication management.